201
TITLE: OFF/-ON-TIME CHANGES AFTER SWITCHING FROM ENTACAPONE OR PLACEBO TO OPICAPONE IN PATIENTS ENDING THE BIPARK-I EXTENSION STUDY ON OPICAPONE 50-MG  Full Text
AUTHORS: Poewe, W; Ferreira, JJ ; Lees, A; Rascol, O; Ikedo, F; Magalhaes, D; Rocha, JF; Soares da Silva, P;
PUBLISHED: 2020, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 79
INDEXED IN: WOS
202
TITLE: Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis
AUTHORS: Mainoli, B; Duarte, GS; Costa, J; Ferreira, J ; Caldeira, D;
PUBLISHED: 2020, SOURCE: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, VOLUME: 21, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 8
203
TITLE: OPICAPONE AS FIRST-LINE ADJUNCTIVE LEVODOPA TREATMENT IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS: BIPARK-I AND II COMBINED POST-HOC ANALYSIS  Full Text
AUTHORS: Ferreira, JJ ; Poewe, W; Antonini, A; Gama, H; Rocha, JF; Magalhaes, D; Soares da Silva, P;
PUBLISHED: 2020, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 79
INDEXED IN: WOS
204
TITLE: Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis  Full Text
AUTHORS: Ferreira, JJ ; Poewe, W; Antonini, A; Gama, H; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
205
TITLE: OPICAPONE'S ADDED BENEFIT AS A FIRST-LINE ADJUNCTIVE THERAPY TO LEVODOPA AND WHEN USED PROMPTLY FOR MOTOR FLUCTUATIONS IN PARKINSON'S DISEASE  Full Text
AUTHORS: Ebersbach, G; Ferreira, JJ ; Antonini, A; Santos, A; Magalhaes, D; Rocha, JF; Soares da Silva, P;
PUBLISHED: 2020, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 79
INDEXED IN: WOS
206
TITLE: Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial
AUTHORS: Hommel, ALAJ; Meinders, MJ; Weerkamp, NJ; Richinger, C; Schmotz, C; Lorenzl, S; Dodel, R; Coelho, M; Ferreira, JJ ; Tison, F; Boraud, T; Meissner, WG; Rosqvist, K; Timpka, J; Odin, P; Wittenberg, M; Bloem, BR; Koopmans, RT; Schrag, A;
PUBLISHED: 2020, SOURCE: JOURNAL OF PARKINSONS DISEASE, VOLUME: 10, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 6
207
TITLE: Outcome Measures for Evaluating the Effect of a Multidisciplinary Intervention on Axial Symptoms of Parkinson's Disease  Full Text
AUTHORS: Bouça Machado, R; Pona Ferreira, F; Gonçalves, N; Leitão, M; Cacho, R; Castro Caldas, A; Ferreira, JJ ; and CNS Multidisciplinary Team;
PUBLISHED: 2020, SOURCE: FRONTIERS IN NEUROLOGY, VOLUME: 11
INDEXED IN: Scopus WOS CrossRef: 7
208
TITLE: Patient characteristics, treatment patterns and disease burden in people with Parkinson's disease: insights from the Parkinson's disease real-world impact assessment (PRISM) study  Full Text
AUTHORS: Foltynie, T; Tolosa, E; Ferreira, JJ ; Antonini, A; Lees, A; Ebersbach, G; Rascol, O; Rocha, JF; Magalhaes, D; Soares Da Silva, P;
PUBLISHED: 2020, SOURCE: 6th Congress of the European-Academy-of-Neurology (EAN) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 27
INDEXED IN: WOS
209
TITLE: Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia  Full Text
AUTHORS: Comella, C; Ferreira, JJ ; Pain, E; Azoulai, M; Om, S;
PUBLISHED: 2020, SOURCE: JOURNAL OF NEUROLOGY, VOLUME: 268, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 21
210
TITLE: Patient-centred management of Parkinson's disease  Full Text
AUTHORS: Grimes, D; Antonini, A; Ferreira, JJ ; Sanchez Ferro, Á; Lynch, T; Rascol, O; Růžička, E; Eggers, C; Mestre, TA;
PUBLISHED: 2020, SOURCE: The Lancet Neurology, VOLUME: 19, ISSUE: 11
INDEXED IN: Scopus CrossRef: 2
Page 21 of 70. Total results: 700.